Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 SEK | -3.57% | +3.05% | -66.21% |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Stenvang
FOU | Founder | - | 31/12/16 |
Chief Executive Officer | 64 | 01/01/23 | |
Johnny Stilou
DFI | Director of Finance/CFO | 57 | 31/07/21 |
Lars Damstrup
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/22 |
Corporate Officer/Principal | - | - | |
Morten Nissen
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 31/03/22 | |
Director/Board Member | 69 | 06/05/18 | |
Martin Møller
CHM | Chairman | 49 | 30/04/21 |
Martine van Vugt
BRD | Director/Board Member | 71 | 31/03/22 |
Director/Board Member | 53 | 31/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,706,972 | 38,542,097 ( 94.68 %) | 0 | 94.68 % |
Company contact information
Scandion Oncology A/S
Symbion Fruebjergvej 3
2100, Copenhagen
+45 38 10 20 17
http://www.scandiononcology.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.21% | 5.27M | |
+7.03% | 111B | |
+10.67% | 106B | |
-12.49% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.80% | 16.81B | |
+39.14% | 12.54B | |
-24.38% | 8.09B |
- Stock Market
- Equities
- SCOL Stock
- Company Scandion Oncology A/S